Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Weiwen Liu; Huihong Xu; Xihui Ying; Dengke Zhang; Linqiang Lai; Linyou Wang; Jianfei Tu; Jiansong Ji

doi:10.12659/MSM.923263

15 July 2020: Clinical Research

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Weiwen Liu ^1ABC , Huihong Xu ^2DE , Xihui Ying ^1EFG , Dengke Zhang ^1CD , Linqiang Lai ^1BC , Linyou Wang ^3EF , Jianfei Tu ^1CFG* , Jiansong Ji ^1BDG*

DOI: 10.12659/MSM.923263

Med Sci Monit 2020; 26:e923263

Authors information Article notes Copyright and License information

View HTML version

Figure 5 Patients with smaller tumor sizes (≤5 cm) had much better OS than those with large tumor sizes (5–10 cm).

Back to the Article

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Your Privacy